Status:
COMPLETED
MK0954 Versus Placebo for Treatment of Mild to Moderate Hypertension
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Hypertension
Eligibility:
All Genders
21+ years
Phase:
PHASE3
Brief Summary
The study had a 4 week single blind placebo period followed by 12 weeks of double blind treatment. Patients were randomized to one of four treatment arms to evaluate the antihypertensive efficacy of L...
Eligibility Criteria
Inclusion
- Patient has been diagnosed with mild to moderate hypertension
- Patient has no treatment or active medical problem, other than hypertension that might affect the patients blood pressure
Exclusion
- Pregnant of lactating female patients
- Secondary hypertension or history of malignant hypertension
- Sitting systolic blood pressure \> 210 mmHg
- History of stroke
- History of myocardial infarction with in the past year
- Current of prior history of heart failure
- Known hypersensitivity to losartan
- Obesity
- Patients known to be HIV positive or known to be positive for Hepatitis B
- Absence of one kidney
- Patient is abusing or previously abused alcohol or drugs with in past two years
Key Trial Info
Start Date :
May 1 1992
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 1993
Estimated Enrollment :
428 Patients enrolled
Trial Details
Trial ID
NCT00888355
Start Date
May 1 1992
End Date
February 1 1993
Last Update
July 9 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.